Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Fujifilm will acquire the shares of Biogen’s subsidiary, which holds Biogen’s biologics manufacturing operations in Hillerød, Denmark.
read more
Monday, November 27, 2017
Biogen and Alkermes announced they have entered into a global license and collaboration agreement to develop and commercialize ALKS 8700.
read more
Thursday, January 05, 2023
Biognosys AG and Bruker Corporation announced a strategic partnership, in which Bruker has made a majority-ownership investment in Biognosys. Financial details were not disclosed.
read more
Biognosys, a provider of proteomics solutions for drug discovery and development, announced the operational readiness of its new proteomics facility in Massachusetts.
read more
Wednesday, December 13, 2017
Science Exchange announced a partnership with Bioinformatics Solutions to offer online access to its protein de novo sequencing services to scientists around the globe.
read more
BioInvent International has signed an agreement with Alligator Bioscience AB to provide process development and manufacturing services for Alligator’s new bispecific antibody, ADC-1015.
read more
BioInvent announced it will receive a $0.5 million milestone payment related to the acceptance by the FDA of the IND application for TAK-169, a first-in-class CD38-targeted fusion protein.
read more
BioIVT, a leading provider of biospecimens, research models and drug and diagnostic development services, acquired Cypex, a renowned manufacturer of recombinant xenobiotic metabolizing enzymes, based in Dundee, Scotland.
read more
BioIVT has acquired Clinical Trials Laboratory Services (CTLS), a donor center and laboratory based in London, UK.
read more
Wednesday, September 14, 2022
BioIVT, a provider of biospecimens, research models and services for drug and diagnostic development, has acquired XenoTech, a provider of products for ADME-Tox in vitro models and contract research services, from Sekisui Chemical, based in Japan. ...
read more
Wednesday, August 21, 2024
BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, has acquired ZenBio Inc., a provider of advanced cell products and services. Together, BioIVT and ZenBio will offer an expanded portfolio of ...
read more
Wednesday, September 10, 2025
BioIVT announced the company is expanding with new office space and a laboratory facility in Woodbury, New York.
read more
BioIVT announced the opening of its new blood donor center on the Tufts University campus in Medford, MA to support academic and pharmaceutical researchers involved in COVID-19, cell and gene therapy research.
read more
Biokin Pharmaceutical and Cryoport announced Cryoport's temperature-controlled solutions will support Biokin Pharma's pending Phase I and II clinical trials in immuno-oncology in both the U.S. and China.
read more
BioLegend and the NYGC have entered into an exclusive worldwide license and collaborative research agreement for CITE-seq technology for use in the research field.
read more